Clinical Trials Logo

Clinical Trial Summary

The definitive treatment of disabling metatarsalgia requires surgery. In recent years, a percutaneous technique has been developed, the "Distal Metatarsal Mini-invasive Osteotomy" (DMMO). It consists of performing extra-articular osteotomies that are not osteosynthesized and maintained during the time of bone consolidation by a dressing and specific offloading footwear.The patient is encouraged to resume walking immediately after the procedure, as full plantar support is an integral part of the surgical concept. The goal is to actively modify the distribution of all metatarsal supports by the pressure exerted on the ground during walking and by tendon tensions, in order to reduce forefoot deformities. DMMO offers many advantages over traditional techniques, but it remains a painful forefoot surgery in the short term despite the systematic use of analgesics and the wearing of a dedicated therapeutic shoe. The study will seek to identify the predictive character of podobarometric parameters at walking (D+7 and D+30 post-op), between patients who will require a palliative solution versus those who will not (D+90)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Distal Metatarsal Mini-invasive Osteotomy (DMMO)

NCT number NCT04823169
Study type Interventional
Source Centre Hospitalier le Mans
Contact Christelle JADEAU
Phone 02 44 71 07 81
Email cjadeau@ch-lemans.fr
Status Recruiting
Phase N/A
Start date March 22, 2021
Completion date September 22, 2023